Business

Ehave Solutions Gain Traction in Cannabis Industry -- CFN Media

Ehave Solutions Gain Traction in Cannabis Industry -- CFN Media.

articleEhave Inc.March 7, 20185/company/ehave-inc/news/ehave-solutions-gain-traction-in-cannabis-industry-cfn-media
Ehave Solutions Gain Traction in Cannabis Industry -- CFN Media

About this update from Ehave Inc.

[{"type":"text","content":"\n\n SEATTLE, WA, March 07, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (\"CannabisFN\"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering recent developments in the deployment of Ehave Inc.’s (OTCQB: EHVVF) Connect platform, an innovative bioinformatics tool that enables researchers, physicians, and patients to connect in a way that was never before possible. By bringing all of these parties together, everyone can work towards the common goal of improving patient outcomes on a highly personalized level.\n The cannabis industry is expected to reach $50 billion by 2022 in the U.S. alone, according to Cowen & Co., driven by a growing number of states that have legalized the drug for medical and adult use. At the same time, a growing number of researchers have become interested in the drug as a potential treatment for a wide range of medical conditions. The problem is that it’s difficult to keep effective records in cannabis clinical trials. Revive Therapeutics Collaboration Ehave recently announced a collaboration agreement with Revive Therapeutics Ltd. to provide enhanced patient and clinical research data management. Under the terms of the agreement, Revive will integrate the Ehave Connect platform with its ongoing research involving the use of medical cannabis for the treatment of liver diseases, including nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and fibrosis. “We are very excited with our collaboration with Ehave as it provides us with a foundation of employing next generation patient and clinical research data management solutions early on in the research and development phase of our liver disease program,” said Revive CEO Craig Leon. “Ehave’s platform will support our research and clinical decisions and it will allow us to make objective, data-driven decisions throughout the course of our research.” The Ehave Connect platform collects and integrates patient data from clinical systems, licensed health surveys, and patient and clinician reported outcomes. By keeping patients engaged throughout the healthcare journey, the platform helps connect teams across disciplines and ensure that patients have the best treatments and options available to them. “Our collaboration ...

More updates from Ehave Inc.